1、REFINITIV STREETEVENTSEDITED TRANSCRIPTJNJ.N-Q2 2025 Johnson&Johnson Earnings CallEVENT DATE/TIME:JULY 16,2025/12:30PM GMTOVERVIEW:Company SummaryREFINITIV STREETEVENTS|Contact Us2025 Refinitiv.All rights reserved.Republication or redistribution of Refinitiv content,including by framing or simil

2、ar means,is prohibited without the prior writtenconsent of Refinitiv.Refinitiv and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.CORPORATE PARTICIPANTSDarren Snellgrove Johnson&Johnson-Vice President,Investor RelationsJoaquin Duato Johnson&Johnson-Cha

3、irman of the Board,Chief Executive OfficerJoseph Wolk Johnson&Johnson-Chief Financial Officer,Executive Vice PresidentJennifer Taubert Johnson&Johnson-Executive Vice President,Worldwide Chairman,Innovative MedicineTim Schmid Johnson&Johnson-Executive Vice President,Worldwide Chairman of

4、MedTechJohn Reed Johnson&Johnson-Executive Vice President,Innovative Medicine,Research and DevelopmentCONFERENCE CALL PARTICIPANTSChristopher Schott JPMorgan Chase&Co-AnalystTerence Flynn Morgan Stanley-AnalystLarry Biegelsen Wells Fargo Securities LLC-AnalystAsad Haider Goldman Sachs Group

5、Inc-AnalystShagun Singh RBC Capital Markets Inc-AnalystAlexandria Hammond Wolfe Research LLC-Equity AnalystDanielle Antalffy UBS AG-AnalystVamil Divan Guggenheim Securities LLC-Equity AnalystPRESENTATIONOperatorGood morning and welcome to Johnson&Johnsons second-quarter 2025 earnings conference

6、call.(Operator Instructions)The conference call isbeing recorded.(Operator Instructions)I will now turn the conference call over to Johnson&Johnson.You may begin.Darren Snellgrove-Johnson&Johnson-Vice President,Investor RelationsHello,everyone.This is Darren Snellgrove,Vice President of Inve